FdaApplication

ANDA 210111

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBRECKENRIDGE PHARMACEUTICAL INC
application_typeANDA
approval_date2020-10-30

Products (4)

ProductActive ingredientStrengthDosage form
POMALIDOMIDEPOMALIDOMIDE2MGCAPSULE;ORAL
POMALIDOMIDEPOMALIDOMIDE4MGCAPSULE;ORAL
POMALIDOMIDEPOMALIDOMIDE1MGCAPSULE;ORAL
POMALIDOMIDEPOMALIDOMIDE3MGCAPSULE;ORAL

4 products